Vitamin Shoppe Inc (VSI) reported quarterly earnings results on Wednesday, Aug-3-2016. The company reported $0.55 earnings per share for the quarter, missing the analyst consensus estimate by $-0.04. Analysts had a consensus of $0.59. The company posted revenue of $332.70 million in the period, compared to analysts expectations of $330.73 million. The company’s revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.57 EPS.
Vitamin Shoppe Inc closed down -0.87 points or -2.98% at $28.28 with 4,92,552 shares getting traded on Tusday. Post opening the session at $29, the shares hit an intraday low of $28.14 and an intraday high of $29.2 and the price fluctuated in this range throughout the day.Shares ended Tusday session in Red.
In a different news, on Jun 1, 2016, Guillermo Marmol (director) purchased 1,000 shares at $30.23 per share price. According to the SEC, on Aug 18, 2015, B. Michael Becker (director) sold 845 shares at $36.74 per share price. On May 26, 2015, Colin Frederick Watts (CEO) purchased 2,400 shares at $41.02 per share price, according to the Form-4 filing with the securities and exchange commission.
Vitamin Shoppe Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins minerals herbs specialty supplements sports nutrition and other health and wellness products (VMS). The Company operates through three segments: retail which includes Vitamin Shoppe Super Supplements and Vitapath retail store formats; direct which consists of its e-commerce and catalog formats and manufacturing which consists of the Nutri-Force manufacturing operations. The Company operates through its wholly owned subsidiary Vitamin Shoppe Industries Inc. and Vitamin Shoppe Industries Inc.s’ wholly owned subsidiaries VS Direct Inc. Vitamin Shoppe Mariner Inc. (VSM) VS Hercules LLC (VSH) Vitamin Shoppe Global Inc. (VSG) and Vitapath Canada Limited (VCL).